Aeterna Zentaris
AEZS
#10196
Rank
S$22.61 M
Marketcap
S$7.39
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): S-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is S-$2.65. In 2022 the company made an earnings per share (EPS) of S-$6.04 a decrease over its 2021 EPS that were of S-$2.35.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$2.77
2022S-$6.04157.14%
2021S-$2.35-41.48%
2020S-$4.02-64.46%
2019S-$11.30-240%
2018S$8.07-122.32%
2017S-$36.15-53.53%
2016S-$77.79-86.71%
2015S-$585.51-35.21%
2014S-$903.77-216.67%
2013S$774.66-123.3%
2012S-$3,325-40.8%
2011S-$5,616-6.45%
2010S-$6,004-27.91%
2009S-$8,328-61.61%
2008S-$21,69083.61%
2007S-$11,814-195.31%
2006S$12,395178.26%
2005S$4,454-330%
2004S-$1,937-80.05%
2003S-$9,70717.78%
2002S-$8,242515.93%
2001S-$1,338-68.6%
2000S-$4,262119.62%
1999S-$1,941-3.63%
1998S-$2,014

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
S-$0.46-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.50-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$3.83-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.78-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
S$6.31-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA